المؤلفون: Hantao Lou, Xuetao Cao

المصدر: Cancer Communications, Vol 42, Iss 9, Pp 804-827 (2022)

مصطلحات موضوعية: antibody engineering, bi/trispecific killer engager, cancer immunotherapy, chimeric antigen receptor‐T (CAR‐T) cell, nanobody, natural killer (NK) cell, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2523-3548

URL الوصول: https://doaj.org/article/09cf713f0c494214a401c94954571733

المؤلفون: Ebru Erdoğan, Koray Yalçın, Cansu Hemşinlioğlu, Aslıhan Sezgin, Utku Seyis, Derya Dilek Kancağı, Cihan Taştan, Bulut Yurtsever, Raife Dilek Turan, Didem Çakırsoy, Selen Abanuz, Gözde Sır Karakuş, Muhammer Elek, Hüseyin Saffet Beköz, Ali İhsan Gemici, Deniz Sargın, Mutlu Arat, Burhan Ferhanoğlu, Ebru Pekgüç, Serdar Örnek, Deram Büyüktaş, Nur Birgen, Siret Ratip, Ercüment Ovalı

المصدر: Turkish Journal of Hematology, Vol 39, Iss 3, Pp 206-210 (2022)

مصطلحات موضوعية: acute lymphoblastic leukemia, chimeric antigen receptor t (car-t) cell, gene therapy, non-hodgkin lymphoma, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-01709; https://doaj.org/toc/1308-5263

URL الوصول: https://doaj.org/article/556bd673500c45ae8473e751960454e8

المؤلفون: Lingzhi Yan, Su Qu, Jingjing Shang, Xiaolan Shi, Liqing Kang, Nan Xu, Mingqing Zhu, Jin Zhou, Song Jin, Weiqin Yao, Ying Yao, Guanghua Chen, Huirong Chang, Xiaming Zhu, Lei Yu, Depei Wu, Chengcheng Fu

المصدر: Cancer Medicine, Vol 10, Iss 2, Pp 563-574 (2021)

مصطلحات موضوعية: chimeric antigen receptor T (CAR T) cell, dose‐escalation, efficacy, multiple myeloma, relapsed and/or refractory, safety, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/ad2f138e95ce43a69f64c1a09ab73154

المؤلفون: Zhao, Houli^{Aff1, Aff2, Aff3}, Wang, Yiyun^{Aff1, Aff2, Aff3}, Yin, Elaine Tan Su^{Aff1, Aff2, Aff3}, Zhao, Kui, Hu, Yongxian^{Aff1, Aff2, Aff3}, Huang, He^{Aff1, Aff2, Aff3}

المصدر: Frontiers of Medicine. 14(6):711-725

المؤلفون: Xinhui Li, Jian Zhou, Weiwen Zhang, Wenhua You, Jun Wang, Linlin Zhou, Lei Liu, Wei-Wei Chen, Hanjie Li

المصدر: Cancers, Vol 14, Iss 22, p 5674 (2022)

مصطلحات موضوعية: pan-cancer analysis, tumor-specific antigens (TSAs), chimeric antigen receptor-T (CAR-T) cell, antibody drug conjugates (ADCs), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2072-6694/14/22/5674; https://doaj.org/toc/2072-6694

URL الوصول: https://doaj.org/article/c70035273ca64963ad05624ffd29f81e

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Yongbin Zheng, Huangrong Cheng, Shuoyang Huang, Chao Yang, Huali Li

المصدر: Journal of Cancer

مصطلحات موضوعية: business.industry, Colorectal cancer, T cell, medicine.medical_treatment, Cell, toxicity, colorectal cancer, Immunotherapy, Review, medicine.disease, tumor associated antigens, medicine.anatomical_structure, Oncology, Antigen, strategies, Cancer research, medicine, Stage (cooking), Car t cells, business, Adverse effect, chimeric antigen receptor-T (CAR-T) cell

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7ac70b357bac9f2451a5090cedfe46a
http://europepmc.org/articles/PMC7890323

المؤلفون: Depei Wu, Xiaolan Shi, Guanghua Chen, Song Jin, Lingzhi Yan, Nan Xu, Chengcheng Fu, Xiaming Zhu, Ming-Qing Zhu, Su Qu, Ying Yao, Huirong Chang, Jin Zhou, Weiqin Yao, Jingjing Shang, Liqing Kang, Lei Yu

المصدر: Cancer Medicine, Vol 10, Iss 2, Pp 563-574 (2021)
Cancer Medicine

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, efficacy, Immunotherapy, Adoptive, 0302 clinical medicine, Multiple myeloma, Original Research, Receptors, Chimeric Antigen, biology, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Survival Rate, multiple myeloma, Tolerability, 030220 oncology & carcinogenesis, Toxicity, relapsed and/or refractory, Female, Cart, safety, medicine.medical_specialty, Antigens, CD19, lcsh:RC254-282, CD19, 03 medical and health sciences, Antigen, Refractory, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, B-Cell Maturation Antigen, Aged, Salvage Therapy, business.industry, Clinical Cancer Research, chimeric antigen receptor T (CAR T) cell, medicine.disease, Chimeric antigen receptor, 030104 developmental biology, Drug Resistance, Neoplasm, biology.protein, dose‐escalation, Neoplasm Recurrence, Local, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ffa533037b06dbc61ed6ede8db46e85
https://doaj.org/article/ad2f138e95ce43a69f64c1a09ab73154

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.